M&A Deal Summary

Viropro Acquires Alpha Biologics Sdn Bhd.

On February 22, 2011, Viropro acquired life science company Alpha Biologics Sdn Bhd.

Acquisition Highlights

This is Viropro’s 1st transaction in the Life Science sector.
This is Viropro’s 1st transaction in Canada.
This is Viropro’s 1st transaction in Quebec.

M&A Deal Summary
Date	2011-02-22
Target	Alpha Biologics Sdn Bhd.
Sector	Life Science
Buyer(s)	Viropro
Deal Type	Add-on Acquisition

Target

Alpha Biologics Sdn Bhd.

Montreal, Quebec, Canada

Alpha Biologics Sdn Bhd. is a contract process development and GMP biomanufacturing company, with process development laboratories.

Search 200,500 Deals Now

SEARCH BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Viropro

San Jose, California, United States

Category	Company
Sector	Life Science

DESCRIPTION

Viropro is a developer and manufacturer of biopharmaceutical products with a state-of-the-art production.

DEAL STATS	#
Overall	1 of 1
Sector (Life Science)	1 of 1
Type (Add-on Acquisition)	1 of 1
State (Quebec)	1 of 1
Country (Canada)	1 of 1
Year (2011)	1 of 1